Oxford Asset Management’s Abiomed Inc ABMD Stock Holding History

Oxford Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,342	Closed	-$2.79M	–	1508
2019 Q4	$2.79M	Buy	+16,342	New	+$3.03M	0.08%	271
2018 Q3	–	Sell	-1,744	Closed	-$723K	–	2001
2018 Q2	$723K	Sell	1,744 -89	-5%	-$32.2K	0.01%	1195
2018 Q1	$533K	Sell	1,833 -5,185	-74%	-$1.31M	0.01%	1220
2017 Q4	$1.34M	Buy	7,018 +4,016	+134%	+$750K	0.03%	785
2017 Q3	$500K	Sell	3,002 -2,452	-45%	-$371K	0.01%	1200
2017 Q2	$782K	Buy	+5,454	New	+$733K	0.02%	967
2016 Q3	–	Sell	-8,721	Closed	-$953K	–	890
2016 Q2	$953K	Buy	+8,721	New	+$868K	0.03%	494
2016 Q1	–	Sell	-33,015	Closed	-$3.02M	–	929
2015 Q4	$3.02M	Buy	+33,015	New	+$2.8M	0.07%	305
2015 Q2	–	Sell	-139,955	Closed	-$10M	–	760
2015 Q1	$10M	Buy	139,955 +35,180	+34%	+$1.91M	0.25%	77
2014 Q4	$4.02M	Buy	+104,775	New	+$3.3M	0.09%	246

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Oxford Asset Management's ABMD Position: Q1 2020 in Review

Oxford Asset Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 16,342 shares — an estimated $2.79M sold.

Oxford Asset Management first reported a position in ABMD in Q4 2014 and held it in 10 quarters. The position peaked at $10M in Q1 2015. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

Oxford Asset Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 16,342 Abiomed Inc shares in Q1 2020, an estimated $2.79M.
Oxford Asset Management first reported a position in Abiomed Inc in Q4 2014 and held it in 10 quarters.
Oxford Asset Management's Abiomed Inc position peaked at $10M in Q1 2015.
412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.